Study designs for clinical trials applied to personalised medicine: a scoping review

OBJECTIVE: Personalised medicine (PM) allows treating patients based on their individual demographic, genomic or biological characteristics for tailoring the ‘right treatment for the right person at the right time’. Robust methodology is required for PM clinical trials, to correctly identify groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Superchi, Cecilia, Brion Bouvier, Florie, Gerardi, Chiara, Carmona, Montserrat, San Miguel, Lorena, Sánchez-Gómez, Luis María, Imaz-Iglesia, Iñaki, Garcia, Paula, Demotes, Jacques, Banzi, Rita, Porcher, Raphaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083424/
https://www.ncbi.nlm.nih.gov/pubmed/35523482
http://dx.doi.org/10.1136/bmjopen-2021-052926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083424/
https://www.ncbi.nlm.nih.gov/pubmed/35523482
http://dx.doi.org/10.1136/bmjopen-2021-052926

Ejemplares similares